Mark Baldry, Chief Commercial Officer at X4 Pharmaceuticals, Inc (XFOR), bought 635,050 shares at $0.68 ($19K) on 2024-05-17, disclosed to the SEC on 2025-02-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.68 | 21,646 | $15K | 76.4% |
| 2 | $0.34 | 13,404 | $5K | 23.6% |
| 3 | $0.00 | 600,000 | $0 | 0.0% |
| Total | $0.03 avg | 635,050 | $19K | 100% |
| Filing → |
| XFOR | SELL | 2023-11-03 | $7K | — | Filing → |